PML AS A POTENTIAL PREDICTIVE FACTOR OF EFFICACY OF OXALIPLATIN BASED FIRST LINE CHEMOTHERAPY IN COLORECTAL CANCER PATIENTS

被引：0
|
作者：
Vincenzi, B. [1 ]
Perrone, G. [1 ]
Santini, D. [1 ]
Loupakis, F. [2 ]
Graziano, F. [3 ]
Ruzzo, A. [4 ]
Venditti, O. [1 ]
OnettiMuda, A. [1 ]
Falcone, A. [2 ]
Tonini, G. [1 ]
机构：
[1] Univ Campus Biomed Rome, Rome, Italy
[2] Ist Toscano Tumori, Dept Oncol, Livomo, Italy
[3] Hosp Pesaro, Med Oncol Unit, Pesaro, Italy
[4] Univ Urbino, Dept Biomol Sci, I-61029 Urbino, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [41] Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis
    Kim, Hye Ryun
    Min, Byung Soh
    Kim, Jin Soo
    Shin, Sang Joon
    Ahn, Joong Bae
    Rho, Jae Kyung
    Kim, Nam Kyu
    Rha, Sun Young
    ONCOLOGY, 2011, 81 (3-4) : 175 - 183
  • [42] Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy.: A report of the AIO Colorectal Study Group
    Mueller, C. I.
    Schulmann, K.
    Reinacher-Schick, A.
    Andre, N.
    Arnold, D.
    Tannapfel, A.
    Arkenau, H.
    Hahn, S. A.
    Schmoll, S. H. -J.
    Porschen, R.
    Schmiegel, W.
    Graeven, U.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (11) : 1033 - 1039
  • [43] Interleukin 8 as predictive factor for response to chemotherapy in colorectal cancer patients
    Burz, Claudia
    Bojan, Anca
    Balacescu, Loredana
    Pop, Vlad-Vasile
    Silaghi, Ciprian
    Lupan, Iulia
    Aldea, Cornel
    Sur, Daniel
    Samasca, Gabriel
    Cainap, Calin
    Chiorean, Bogdan
    ACTA CLINICA BELGICA, 2021, 76 (02) : 113 - 118
  • [44] Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group
    C. I. Müller
    K. Schulmann
    A. Reinacher-Schick
    N. Andre
    D. Arnold
    A. Tannapfel
    H. Arkenau
    S. A. Hahn
    S. H.-J. Schmoll
    R. Porschen
    W. Schmiegel
    U. Graeven
    International Journal of Colorectal Disease, 2008, 23 : 1033 - 1039
  • [45] Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer
    Puthillath, Ajithkumar
    Dunn, Kelli Bullard
    Rajput, Ashwani
    Smith, Judy
    Yang, Gary
    Wilding, Gregory E.
    Tan, Wei
    Gupta, Bhavna
    Fakih, Marwan G.
    CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 710 - 715
  • [46] Oxaliplatin-based chemotherapy in the management of colorectal cancer
    Capdevila, Jaume
    Elez, Elena
    Peralta, Sergio
    Macarulla, Teresa
    Javier Ramos, Francisco
    Tabernero, Josep
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1223 - 1236
  • [47] Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study
    Imai, Hiroo
    Saijo, Ken
    Komine, Keigo
    Ueta, Reio
    Numakura, Ryunosuke
    Wakayama, Shonosuke
    Umegaki, Sho
    Hiraide, Sakura
    Kawamura, Yoshifumi
    Kasahara, Yuki
    Ohuchi, Kota
    Takahashi, Masahiro
    Takahashi, Shin
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1259 - 1266
  • [48] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS STANDARD FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: FIRST BEAT
    Van Cutsem, E.
    Berry, S.
    Michael, M.
    Kretzschmar, A.
    Rivera, F.
    DiBartolomeo, M.
    Mazier, M.
    Andre, N.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [49] hSRBC promoter CpG island hypermethylation as resistant predictive biomarker of oxaliplatin based chemotherapy in metastasic colorectal cancer patients
    Moutinho, Catia
    Martinez-Cardus, Anna
    Santos, Cristina
    Navarro-Perez, Valentin
    Martinez-Balibrea, Eva
    Esteve, Albert Abad
    Salazar, Ramon
    Esteller, Manel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
    Stec, Rafal
    Bodnar, Lubomir
    Charkiewicz, Radoslaw
    Korniluk, Jan
    Rokita, Marta
    Smoter, Marta
    Ciechowicz, Marzena
    Chyczewski, Lech
    Niklinski, Jacek
    Kozlowski, Wojciech
    Szczylik, Cezary
    CANCER BIOLOGY & THERAPY, 2012, 13 (13) : 1235 - 1243
12345